Smith Anglin Financial’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Smith Anglin Financial's PFE Position: Q2 2025 in Review
Smith Anglin Financial sold out of Pfizer (PFE) in Q2 2025, closing a stake of 10,211 shares — an estimated $259K sold.
Smith Anglin Financial first reported a position in PFE in Q4 2020 and held it in 17 quarters. The position peaked at $652K in Q3 2024. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.
- Smith Anglin Financial reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
- Smith Anglin Financial sold 10,211 Pfizer shares in Q2 2025, an estimated $259K.
- Smith Anglin Financial first reported a position in Pfizer in Q4 2020 and held it in 17 quarters.
- Smith Anglin Financial's Pfizer position peaked at $652K in Q3 2024.
- 2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.
Based on Smith Anglin Financial's 13F filing for Q2 2025, filed 17 Jul 2025.